Showing 1 - 8 of 8
Several characteristics of biotech industry structure follow cyclical patterns. Mergers and acquisitions activity shows cyclical behavior, with peaks from 1988-92 and 1996-97 and a valley from 1993-95. The ratio of large-firm to small-firm field trials, and the Herfindahl-Hirshmann concentration...
Persistent link: https://www.econbiz.de/10005469374
Over the past fifteen years, the agricultural biotechnology industry has exhibited cyclical behavior in concentration and consolidation. This paper provides a theoretical model of endogenous R&D, in which industry concentration exhibits cyclical behavior. The model also generates additional...
Persistent link: https://www.econbiz.de/10005476377
Persistent link: https://www.econbiz.de/10003348944
Persistent link: https://www.econbiz.de/10003872258
Persistent link: https://www.econbiz.de/10009949041
Recent discussions of a subtherapeutic antibiotic ban in U.S. livestock gives rise to much speculation regarding industry impacts. Swine producers are heterogeneous; thus, a ban on subtherapeutic antibiotics could affect producers of different sizes, cost structures, different production systems...
Persistent link: https://www.econbiz.de/10008503248
"It is further the policy of the Congress to promote the efficient production, marketing, distribution, and utilization of products of the farm as essential to the health and welfare of our peoples and to promote a sound and prosperous agriculture and rural life...It shall be the object and duty...
Persistent link: https://www.econbiz.de/10005514083
The Land Grant College and University (LGCU) research system is in a state of confusion. Public research privatization, industry concentration, and balancing money and the Land Grant mission are issues LGCUs currently face. The ag-biotechnology revolution complicates these issues. This paper...
Persistent link: https://www.econbiz.de/10005514088